Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 5, 2013, Pages 628-634

  Yang, Bo ^a   Sun, Hang ^a   Lin, Wei ^a   Hou, Wugang ^a   Li, Hang ^a   Zhang, Liying ^a   Li, Fanfan ^a   Gu, Yu ^a   Song, Yue ^a   Li, Qing ^a   Zhang, Feng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

5 Methylcytosine; Global DNA hypomethylation; Immunohistochemistry; Prostate cancer

Indexed keywords

5 METHYLCYTOSINE;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA METHYLATION; GLEASON SCORE; HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; MALE; NEEDLE BIOPSY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN BLOOD LEVEL;

5-METHYLCYTOSINE; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DNA METHYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84879462674     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.05.009     Document Type: Article

References (21)

1. Pogribny I.P., Beland F.A. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci 2009, 66:2249-2261.
2. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 2009, 1:239-259.
3. Goelz S.E., Vogelstein B., Hamilton S.R., et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985, 228:187-190.
4. Eden A., Gaudet F., Waghmare A., et al. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.
5. Bedford M.T., van Helden P.D. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 1987, 47:5274-5276.
6. Yegnasubramanian S., Haffner M.C., Zhang Y., et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 2008, 68:8954-8967.
7. Szwagierczak A., Bultmann S., Schmidt C.S., et al. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 2010, 38:e181.
8. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
9. Tahiliani M., Koh K.P., Shen Y., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
10. Nestor C., Ruzov A., Meehan R., et al. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 2010, 48:317-319.
11. Jin S.G., Kadam S., Pfeifer G.P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 2010, 38:e125.
12. Huang Y., Pastor W.A., Shen Y., et al. The behavior of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010, 5:e8888.
13. Hristov A.C., Cope L., Di Cello F., et al. HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma. Mod Pathol 2010, 23:98-104.
14. Gama-Sosa M.A., Slagel V.A., Trewyn R.W., et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983, 11:6883-6894.
15. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92.
16. Kanai Y. Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci 2010, 101:36-45.
17. Brothman A.R., Swanson G., Maxwell T.M., et al. Global hypomethylation is common in prostate cancer cells: A quantitative predictor for clinical outcome?. Cancer Genet Cytogenet 2005, 156:31-36.
18. Mohamed M.A., Greif P.A., Diamond J., et al. Epigenetic events, remodeling enzymes, and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007, 99:908-915.
19. Morey Kinney S.R., Smiraglia D.J., James S.R., et al. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Res 2008, 6:1365-1374.
20. Kinney S.R., Moser M.T., Pascual M., et al. Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer. Mol Cell Biol 2010, 30:4159-4174.
21. Yamada Y., Jackson-Grusby L., Linhart H., et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci U S A 2005, 102:13580-13585.